Financhill
Back

Enovis 10K Form

Sell
23

ENOV
Enovis

Last Price:
$31.82
Seasonality Move:
3.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ENOV News And Ratings

See the #1 stock for the next 7 days that we like better than ENOV

ENOV Financial Statistics

Sales & Book Value

Annual Sales: $2.1B
Cash Flow: $-44.9M
Price / Cash Flow: 0
Annual Sales: $45.84
Price / Book: 0.69

Profitability

EPS (TTM): -13.95000
Net Income (TTM): $-809.5M
Gross Margin: $1.2B
Return on Equity: -26.77%
Return on Assets: -15.53%

Enovis Earnings Forecast

Key Enovis Financial Ratios

  • The Gross Profit Margin over the past 21 years for ENOV is 56.02%.
  • The Selling, General & Administrative Expenses for ENOV have been equal to 48.74% of Gross Profit Margin.
  • The Research & Development expenses have been 4.33% of Revenue.
  • The Net Earning history of ENOV is -39.17% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 9 years.

Enovis Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: ENOV
Website: enovis.com

Debt

Debt-to-Equity Ratio: 0.53
Current Ratio: 2.55
Quick Ratio: 0.99

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 9.25

ENOV Technical Analysis vs Fundamental Analysis

Sell
23
Enovis (ENOV) is a Sell

Is Enovis a Buy or a Sell?

  • Enovis stock is rated a Sell
    The current Enovis [ENOV] share price is $31.60. The Score for ENOV is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.